Preoperative exercise therapy for surgery triggered inflammation

手术前运动疗法引发炎症

基本信息

  • 批准号:
    10684527
  • 负责人:
  • 金额:
    $ 36.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-16 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Liver ischemia and reperfusion (I/R) is an unavoidable consequence of major liver resection and liver transplantation that leads to significant morbidity, mortality, and costs after liver surgery. However, previous strategies to protect the liver from I/R injury have focused on one specific known injury mechanisms, leaving intact other detrimental processes. Pre/post-operative exercise facilitates recovery after major abdominal surgery. It is known that exercise confers beneficial effects on the surgical outcome by regulating multiple mechanisms, including alteration of quantity and function of innate immune cells to provide an anti- inflammatory environment. Our novel preliminary data indicate that preoperative exercise therapy (PET) significantly reduced serum aminotransferase levels (liver damage) and expression of cytokines and chemokines (inflammatory responses) during liver I/R. Our single-cell RNA-sequencing (scRNA-seq) data revealed PET altered the transcriptomic profile of resident Kupffer cells (KCs) towards an anti-inflammatory profile. PET also promoted the anti-inflammatory trained immunity in Kupffer cells which is associated with increased circulating damage-associated molecular pattern (DAMP) IL-33 and itaconate metabolic reprogramming. Furthermore, we show that PET significantly decreased the number of neutrophils and formation of neutrophil extracellular traps (NETs), as key mediators of local and systemic injury after liver I/R. Given these findings, we hypothesize that PET prevents liver I/R injury by altering the trained immunity in Kupffer cells, and the NET-induced local and systemic inflammatory response. We will test our hypothesis by pursuing two specific aims. In Aim 1, we will determine the mechanism by which PET protects the liver from I/R injury via training Kupffer cells towards an anti-inflammatory phenotype. We will test the hypothesis that PET induces an anti-inflammatory trained immunity in KCs via modulation of IL-33/ST2/STAT3 signaling pathway and itaconate/IRG1 metabolic reprogramming pathway. In Aim 2, we will define the role of PET in attenuating local and systemic injury during liver I/R via reduction of neutrophil extracellular traps. We will test the hypothesis that PET ameliorates systemic inflammatory injury after liver I/R through suppression of neutrophil recruitment and formation of NETs. Our proposal will delineate the molecular mechanisms of PET in the regulation of hepatic immune microenvironment, and systemic immunity during liver I/R. The mechanisms discovered in these studies will provide the foundation for not only optimizing this non-pharmacological-based strategy against surgery-induced organ injury but also devising exercise-mimicking pharmacological strategies for patients undergoing surgery who are exercise intolerant.
项目摘要 肝缺血再灌注(I/R)是肝切除术后不可避免的结果, 肝移植导致肝脏手术后显著的发病率、死亡率和成本。但此前的 保护肝脏免受I/R损伤的策略集中于一种特定的已知损伤机制, 其他有害过程。术前/术后锻炼有助于大腹部手术后的恢复 手术众所周知,运动通过调节多个细胞因子, 机制,包括先天免疫细胞的数量和功能的改变,以提供抗- 炎症环境。我们新的初步数据表明,术前运动疗法(PET) 显著降低血清转氨酶水平(肝损伤)和细胞因子表达, 趋化因子(炎症反应)在肝脏I/R。我们的单细胞RNA测序(scRNA-seq)数据 显示PET改变了常驻Kupffer细胞(KCs)的转录组学特征,使其具有抗炎作用。 profile. PET还促进枯否细胞中的抗炎训练免疫,这与 循环损伤相关分子模式(DAMP)IL-33和衣康酸代谢增加 重新编程此外,我们发现PET显著减少了中性粒细胞的数量, 中性粒细胞胞外陷阱(NETs)的形成,是肝脏I/R后局部和全身损伤的关键介质。 鉴于这些发现,我们假设PET通过改变训练的免疫力来预防肝脏I/R损伤。 在枯否细胞中,以及NET诱导的局部和全身炎症反应。我们将测试我们的 通过追求两个具体目标的假设。在目标1中,我们将确定PET保护的机制。 通过将枯否细胞训练为抗炎表型,使肝脏免受I/R损伤。我们将测试 PET通过调节IL-33/ST 2/STAT 3在KC中诱导抗炎训练免疫的假设 信号通路和衣康酸/IRG 1代谢重编程通路。在目标2中,我们将定义 PET通过减少中性粒细胞胞外陷阱减轻肝I/R期间局部和全身损伤。我们 将检验PET通过抑制肝脏I/R后的炎症反应来改善全身炎症损伤的假设。 中性粒细胞募集和NET的形成。我们的建议将描绘PET在 肝脏免疫微环境的调节及肝脏I/R时的全身免疫。的机制 在这些研究中发现的,不仅将为优化这种非药理学基础的 针对手术引起器官损伤的策略,同时也设计了模拟运动的药理学策略 运动不耐受的手术患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hai Huang其他文献

Hai Huang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hai Huang', 18)}}的其他基金

Preoperative exercise therapy for surgery triggered inflammation
手术前运动疗法引发炎症
  • 批准号:
    10701043
  • 财政年份:
    2022
  • 资助金额:
    $ 36.01万
  • 项目类别:
Preoperative exercise therapy modulates neutrophil extracellular trap formation
术前运动疗法调节中性粒细胞胞外陷阱的形成
  • 批准号:
    10810353
  • 财政年份:
    2022
  • 资助金额:
    $ 36.01万
  • 项目类别:
Preoperative exercise therapy for surgery triggered inflammation
手术前运动疗法引发炎症
  • 批准号:
    10263293
  • 财政年份:
    2020
  • 资助金额:
    $ 36.01万
  • 项目类别:
Surgery triggered immune response and liver metastases
手术引发免疫反应和肝转移
  • 批准号:
    10522248
  • 财政年份:
    2018
  • 资助金额:
    $ 36.01万
  • 项目类别:
Synaptic mechanisms of auditory information processing
听觉信息处理的突触机制
  • 批准号:
    9917764
  • 财政年份:
    2018
  • 资助金额:
    $ 36.01万
  • 项目类别:
Synaptic mechanisms of auditory information processing
听觉信息处理的突触机制
  • 批准号:
    10369617
  • 财政年份:
    2018
  • 资助金额:
    $ 36.01万
  • 项目类别:
Synaptic mechanisms of auditory information processing
听觉信息处理的突触机制
  • 批准号:
    10132290
  • 财政年份:
    2018
  • 资助金额:
    $ 36.01万
  • 项目类别:
Ion channels and presynaptic function of an auditory synapse
听觉突触的离子通道和突触前功能
  • 批准号:
    9113559
  • 财政年份:
    2014
  • 资助金额:
    $ 36.01万
  • 项目类别:
Ion channels and presynaptic function of an auditory synapse
听觉突触的离子通道和突触前功能
  • 批准号:
    8896102
  • 财政年份:
    2014
  • 资助金额:
    $ 36.01万
  • 项目类别:
Ion channels and presynaptic function of an auditory synapse
听觉突触的离子通道和突触前功能
  • 批准号:
    8224988
  • 财政年份:
    2012
  • 资助金额:
    $ 36.01万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 36.01万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 36.01万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 36.01万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 36.01万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 36.01万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 36.01万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 36.01万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 36.01万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 36.01万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 36.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了